SEC Form 4 · accession 0001127602-19-009261
LEXICON PHARMACEUTICALS, INC. · LXRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pablo Lapuerta
Officer — EVP and CMO
Period of report
Feb 28, 2019
Accepted (ET)
Mar 1, 2019 · 5:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001062822
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2019 | M | 4,550 | — | A | 38,525 | D | |
| Common StockF1 | Feb 28, 2019 | M | 4,227 | — | A | 42,752 | D | |
| Common StockF1 | Feb 28, 2019 | M | 2,585 | — | A | 45,337 | D | |
| Common StockF1 | Feb 28, 2019 | M | 8,570 | — | A | 53,907 | D | |
| Common Stock | Feb 28, 2019 | F | 6,809 | $5.51 | D | 47,098 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F3 | — | Feb 28, 2019 | M | 4,550 | D | — | — | Common Stock | 4,550 | 0 | D |
| Restricted Stock UnitsF1,F4 | — | Feb 28, 2019 | M | 4,227 | D | — | — | Common Stock | 4,227 | 4,228 | D |
| Restricted Stock UnitsF1,F5 | — | Feb 28, 2019 | M | 2,585 | D | — | — | Common Stock | 2,585 | 5,170 | D |
| Restricted Stock UnitsF1,F6 | — | Feb 28, 2019 | M | 8,570 | D | — | — | Common Stock | 8,570 | 17,140 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of common stock.
- F2Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- F3Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2016 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- F4Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2017 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- F5Restricted stock units vest with respect to 25% of the shares subject to the restricted stock units on February 28, 2018 and vest an additional 25% on February 28 of each of the three succeeding years thereafter.
- F6Restricted stock units vest with respect to one third of the shares subject to the restricted stock units on February 28, 2019 and vest an additional one third on February 28 of each of the two succeeding years thereafter.